Quarterly report pursuant to Section 13 or 15(d)

EARNINGS (LOSS) PER SHARE -Schedule of Earnings (Loss) Per Share (Details)

v3.23.3
EARNINGS (LOSS) PER SHARE -Schedule of Earnings (Loss) Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                
Net income (loss) $ 608,444 $ 93,687 $ 523,054 $ (18,472) $ 256,580 $ (491,975) $ 1,225,185 $ (253,867)
Dividends on preferred stock (1,133)     (1,309)     (3,718) (4,136)
Participating securities - preferred stock (89,756)     0     (180,394) 0
Net income (loss) attributable to common stockholders 517,555     (19,781)     1,041,073 (258,003)
Re-allocation of participating securities 1,147     0     2,043 0
Diluted net income (loss) attributable to common stockholders $ 518,702     $ (19,781)     $ 1,043,116 $ (258,003)
Basic shares (in shares) 18,670,000     19,635,000     18,686,000 20,514,000
Dilutive shares (in shares) 18,954,000     19,635,000     18,937,000 20,514,000
Basic EPS (in usd per share) $ 27.72     $ (1.01)     $ 55.72 $ (12.58)
Dilutive EPS (in usd per share) $ 27.37     $ (1.01)     $ 55.08 $ (12.58)
Restricted Stock                
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                
Dilutive shares (in shares) 300,000     0     300,000 0
Anti-dilutive shares (in shares)       1,200,000       1,500,000
Series A Convertible Preferred Stock                
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                
Anti-dilutive shares (in shares) 3,200,000     3,700,000     3,200,000 3,700,000